{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:14:01Z","timestamp":1769638441021,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1203,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.seizure.2010.01.003","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T04:18:41Z","timestamp":1265343521000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Levetiracetam in the treatment of neonatal seizures: A pilot study"],"prefix":"10.1016","volume":"19","author":[{"given":"Alexandra","family":"F\u00fcrwentsches","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Bussmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Ramantani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Philippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"P\u00f6schl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietz","family":"Rating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seizure.2010.01.003_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(99)70374-4","article-title":"The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study","volume":"134","author":"Ronen","year":"1999","journal-title":"The Journal of Pediatrics"},{"issue":"2","key":"10.1016\/j.seizure.2010.01.003_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00019052-200304000-00010","article-title":"Neonatal seizures and their treatment","volume":"16","author":"Rennie","year":"2003","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.seizure.2010.01.003_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2003.tb07517.x","article-title":"Antiepileptic drugs and apoptosis in the developing brain","volume":"993","author":"Bittigau","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.seizure.2010.01.003_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3476(79)80507-7","article-title":"Side effects of phenobarbital in toddlers","volume":"95","author":"Camfield","year":"1979","journal-title":"The Journal of Pediatrics"},{"issue":"11","key":"10.1016\/j.seizure.2010.01.003_bib5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2010.01.003_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001756-200303030-00035","article-title":"Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons","volume":"14","author":"Angehagen","year":"2003","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.seizure.2010.01.003_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyanetz","year":"2002","journal-title":"Epilepsia"},{"issue":"26","key":"10.1016\/j.seizure.2010.01.003_bib8","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.seizure.2010.01.003_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.seizure.2010.01.003_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1528-1167.2007.01090.x","article-title":"Pharmacokinetics of levetiracetam in infants and young children with epilepsy","volume":"48","author":"Glauser","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2010.01.003_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2001.00005.x","article-title":"Pharmacokinetics of levetiracetam","volume":"42","author":"Radtke","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2010.01.003_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2001.00007.x","article-title":"Efficacy of levetiracetam: a review of three pivotal clinical trials","volume":"42","author":"Privitera","year":"2001","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2010.01.003_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2005.08.002","article-title":"Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany","volume":"14","author":"Opp","year":"2005","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2010.01.003_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","article-title":"Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain","volume":"193","author":"Manthey","year":"2005","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2010.01.003_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/seiz.2000.0511","article-title":"Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia","volume":"10","author":"Hanon","year":"2001","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2010.01.003_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"L\u00f6scher","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.seizure.2010.01.003_bib17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.lfs.2003.08.006","article-title":"Levetiracetam protects against kainic acid-induced toxicity","volume":"74","author":"Marini","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/j.seizure.2010.01.003_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2007.12.069","article-title":"HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam","volume":"1199","author":"Trollmann","year":"2008","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/j.seizure.2010.01.003_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","article-title":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","volume":"16","author":"Grosso","year":"2007","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2010.01.003_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","article-title":"Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy","volume":"14","author":"Grosso","year":"2005","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2010.01.003_bib21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2007.01003.x","article-title":"Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review","volume":"48","author":"Perry","year":"2007","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2010.01.003_bib22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/01.wnl.0000279379.32754.8b","article-title":"Response of infantile spasms to levetiracetam","volume":"70","author":"Mikati","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2010.01.003_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000265222.24102.db","article-title":"An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy","volume":"69","author":"Striano","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2010.01.003_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2007.11.003","article-title":"Intravenous levetiracetam in children with epilepsy","volume":"38","author":"Goraya","year":"2008","journal-title":"Pediatric Neurology"},{"issue":"1","key":"10.1016\/j.seizure.2010.01.003_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0883073807299973","article-title":"Levetiracetam for the treatment of neonatal seizures","volume":"22","author":"Shoemaker","year":"2007","journal-title":"Journal of Child Neurology"},{"issue":"12","key":"10.1016\/j.seizure.2010.01.003_bib26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.37.12.1837","article-title":"Characterization and classification of neonatal seizures","volume":"37","author":"Mizrahi","year":"1987","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2010.01.003_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.seizure.2010.01.003_bib28","doi-asserted-by":"crossref","first-page":"F187","DOI":"10.1136\/adc.2005.086314","article-title":"Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures","volume":"93","author":"Murray","year":"2008","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"4","key":"10.1016\/j.seizure.2010.01.003_bib29","first-page":"CD004218","article-title":"Anticonvulsants for neonates with seizures","volume":"18","author":"Booth","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.seizure.2010.01.003_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0887-8994(02)00621-5","article-title":"Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use","volume":"28","author":"Scher","year":"2003","journal-title":"Pediatric Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111000004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111000004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:38:08Z","timestamp":1761010688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111000004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S105913111000004X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.01.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam in the treatment of neonatal seizures: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}